Tag: IIH
Serenity gains “landmark” US FDA humanitarian device exemption for novel cerebral...
Serenity Medical, a NeuroTechnology Investors (NTI) portfolio company, has today announced a “landmark” US Food and Drug Administration (FDA) humanitarian device exemption (HDE) approval for its novel...
“First-of-its-kind” study demonstrates Monopoint system’s utility in IIH treatment
Route 92 Medical has announced the results of a “first-of-its-kind” multicentre study—published recently in Stroke: Vascular and Interventional Neurology—demonstrating the utility of the company’s...
Safety of venous sinus stenting in IIH patients established via one-year...
A prospective study has established the safety of venous sinus stenting (VSS) using a novel device in idiopathic intracranial hypertension (IIH) patients who have...
Meta-analysis deems venous sinus stenting a safe and effective option in...
A meta-analysis published recently in the Journal of the Neurological Sciences has concluded that venous sinus stenting (VSS) appears to be a safe and...
